**Core tip:** A significant percentage of coronary artery disease patients undergo cardiac surgery so defining outcome predictors is essential for risk calculation and is necessary for estimation of resource utilization and provision of services. Employing global knowledge on this issue is not justified without adjustment for regional specifications and needs. This study aimed at clarifying the role of opium addiction in predicting long-term mortality of coronary artery bypass graft surgery in addition to advanced age, low ejection fraction, diabetes mellitus and cerebrovascular accident.

INTRODUCTION
============

Growing number of patients undergoing coronary artery bypass graft (CABG) surgery all over the world\[[@B1]\], justifies studying on possible predicting factors of clinical outcomes such as short and long-term survival. There are published reports of some predictive factors responsible for short-term mortality such as advanced age, previous history of cardiac surgery and myocardial infarction, non-cardiac comorbidities, New York Heart Association functional class (FC) III or IV and serum creatinine (Cr) level\[[@B2],[@B3]\]. Also some additional factors have been suggested for intermediate-term mortality including left ventricular ejection fraction (EF) and history of percutaneous coronary stenting\[[@B2],[@B4]\]. Similarly, long-term survival could be influenced by diabetes mellitus\[[@B5]\], hypoalbuminemia\[[@B6]\], female gender, smoking, cardiogenic shock\[[@B7]\] and severe preoperative renal dysfunction\[[@B3],[@B8]\].

Coronary artery disease (CAD) has a high prevalence in Iranian population, affecting 22.2% of men and 37.5% of women\[[@B9]\]. In addition, opium is the major abused substance in Iran\[[@B10]\] and the prevalence of opium addiction is believed to be higher in CAD patients undergoing revascularization\[[@B11]\]. The predictive role of opium in short-term outcomes of patients undergoing CABG is controversial. Some investigations have suggested cardiac protective role for opium during ischemic events\[[@B12],[@B13]\]. In a propensity-matched study, Sadeghian et al\[[@B14]\] found no association between opium dependence and post CABG in-hospital complications. On the other hand, in Safaii et al\[[@B15]\]'s study, six months post-CABG readmission was significantly more frequent in opium users. However, there are few evidences to clarify the definite relationship between chronic opium abuse and long-term survival in cardiac surgery patients.

So not only there is limited knowledge regarding the adverse impact of opium consumption on long-term survival of CABG patients, but also the available studies on short-term outcomes have shown controversial results. Therefore in this study we aimed to assess the impact of chronic opium consumption on long-term survival of patients who underwent isolated CABG in a cardiac tertiary center.

MATERIALS AND METHODS
=====================

Patients and methods
--------------------

In the present cohort study (Tehran Heart Center Cardiac Output Measurement)\[[@B16]\], 566 consecutive CAD patients who underwent isolated CABG during six months (April 2006-September 2006) at THC, a high-volume specialized heart tertiary care center, were identified and after signing the informed consent were entered the study. Exclusion criteria were concomitant replacement or repair of heart valve, ventricular aneurism resection or any surgeries other than CABG.

Data collection
---------------

Patients' demographic characteristics including age, gender, weight, waist circumference, body mass index (BMI) as well as their initial laboratory measurements were recorded in previously defined data sheets and were completed from THC surgery database\[[@B17]\] in case of missing information. Family and drug history, associated comorbidities, habitual habits, FC and left ventricular EF were also among documented variables. Regular daily consumption of opium along with fulfilling DSM-IV-TR criteria for opium dependence was considered for opium addiction\[[@B11],[@B18]\].

EuroSCORE was also calculated for all study population and were categorized as low risk (0-2), medium risk (3-5), high risk (6-8) and very high risk (≥ 9) based on what has been previously reported in literature\[[@B19],[@B20]\].

Follow-up
---------

CABG Patients were followed at 4 and 12 mo following the operation through the organized regular visits at CABG follow-up clinic or by telephone interviews. Meanwhile, any outpatient or inpatient services thereafter are recorded precisely in patients' electronic medical file at our institution by the initial unique code. But for the specific purpose of our study in evaluation of long-term survival, we contacted patients by telephone to attend at hospital to be followed 7 years after the cardiac surgery. The precise date of patients' attendance was recorded.

In these long-term follow-up sessions, all patients were investigated for survival status. FC and EF along with further laboratory assessments were also assessed. For non-responders, mortality tracking as well as the exact time and to somehow the etiology of death was noted through telephone interviews with patients' relatives or by checking up the online registration of deaths. For surviving non-responders, the last attendance at THC for receiving any services was considered as the last time of follow-up. The latter group was defined as incomplete follow-up.

Statistical analysis
--------------------

Continuous variables were presented as mean and standard deviation (SD) or median with 25^th^ and 75^th^ percentiles, and were compared between two groups of opium usage using independent samples *t* or Mann-Whitney *U* test. Categorical variables were expressed as frequency and percentage and were compared between aforementioned groups applying χ^2^ or Fisher's exact test. Survival probabilities were estimated using Kaplan-Meier method and their 95%CI were calculated through log-transformed method. The univariate effect of variables on long-term mortality was evaluated using Cox proportional hazards (PH) regression. All variables with *P* values less than 0.2 in the univariate analysis were candidate to enter the multivariable model. A backward stepwise Cox PH model, with removal and entry probabilities as 0.1 and 0.05 respectively, was applied to find the multiple predictors of long-term mortality. The PH assumption was checked through the χ^2^ test of the correlation coefficient between transformed survival time and scaled Schoenfeld residuals. Those variables which simultaneously associated with opium usage and long-term mortality with *P* values less than 0.2 were detected as potential confounders. The effect of opium on long-term mortality adjusted for potential confounders was assessed using Cox PH model. All effects on long-term mortality were reported through hazards ratio (HR) with 95%CI. Softwares IBM SPSS statistics for windows version 22 (Armonk, NY: IBM Corp.) and STATA (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP.) were used to conduct the analyses.

RESULTS
=======

Based on findings, among 566 patients, 53 (9.4%) deaths occurred during the 6.5 years of follow-up among which 40.9% was cardiac and 59.1% was of non-cardiac cause. Median follow-up time for all of the study population was 78.7 mo (95%CI: 78.5-78.9). Median (25^th^-75^th^ interquartile range) follow-up time of 235 patients with incomplete follow-up was 74.6 (25^th^-75^th^: 73.5-75.7) mo.

Patients' demographics characteristics and risk factors: Table [1](#T1){ref-type="table"} demonstrates patients' baseline demographic and clinical characteristics by survival status. According to univariate analysis, age, blood urea nitrogen and high-density lipoprotein levels were significantly lower and EF, albumin and triglyceride levels were significantly higher among survivors. Moreover, opium consumption, diabetes mellitus, cerebrovascular accident and peripheral vascular disease were significantly more frequent among the expired cases.

###### 

Basic demographic and clinical characteristics of patients, univariate analysis for overall survival using Cox regression

                             **Alive (*n* = 513)**   **Dead (*n* = 53)**   **Hazard ratio (95%CI)**   ***P* value**
  -------------------------- ----------------------- --------------------- -------------------------- ---------------
  Age (yr)                   58.5 ± 8.81             64.6 ± 8.27           1.08 (1.044-1.117)         \< 0.001
  Gender (male)              382 (74.5)              43 (81.1)             1.425 (0.716-2.837)        0.313
  BMI (kg/m^2^)              27.4 ± 4.04             26.5 ± 4.39           0.947 (0.881-1.019)        0.146
  Waist circumference (cm)   101.3 ± 1.46            100.2 ± 2.95          0.962 (0.85-1.09)          0.543
  FC                                                                                                  0.141
  I                          177 (34.6)              21 (39.6)                                        
  II                         263 (51.5)              20 (37.7)             0.701 (0.379-1.295)        0.256
  III                        71 (13.9)               12 (22.6)             1.433 (0.702-2.924)        0.323
  EF (%)                     49.1 ± 10.07            42.2 ± 11.07          0.94 (0.915-0.965)         \< 0.001
  FH                         251 (49.1)              18 (34)               0.5 (0.282-0.887)          0.018
  Smoking                    183 (35.8)              20 (37.7)             0.954 (0.542-1.678)        0.870
  Alcohol                    66 (13.7)               5 (9.8)               0.523 (0.201-1.363)        0.185
  Opium                      69 (13.5)               13 (24.5)             1.939 (1.032-3.644)        0.040
  DM                         204 (39.9)              28 (52.8)             1.789 (1.033-3.097)        0.038
  HLP                        366 (71.6)              32 (60.4)             0.58 (0.334-1.008)         0.053
  HTN                        253 (49.5)              26 (49.1)             1.033 (0.602-1.774)        0.906
  CVA                        16 (3.1)                6 (11.3)              4.146 (1.761-9.76)         0.001
  PVD                        136 (26.6)              22 (41.5)             2.166 (1.246-3.766)        0.006
  MI                         254 (49.9)              32 (61.5)             1.61 (0.92-2.816)          0.095
  Alb (g/dL)                 4.6 ± 0.32              4.5 ± 0.39            0.351 (0.16-0.77)          0.009
  FBS                        96 (87-117)             98 (84-124)           1.004 (0.997-1.011)        0.266
  BUN                        38 (31-46)              40 (33-52)            1.035 (1.016-1.054)        \< 0.001
  Cr                         1.2 ± 0.27              1.3 ± 0.26            2.009 (0.832-4.856)        0.121
  Mg                         1.9 ± 0.34              1.9 ± 0.39            1.15 (0.421-3.143)         0.785
  HCT                        42.3 ± 5.92             42.8 ± 3.82           1.013 (0.979-1.047)        0.462
  TG                         165 (115-210)           126 (97-173)          0.994 (0.990-0.999)        0.010
  Chol                       160 ± 44.86             166.3 ± 48.06         1.003 (0.997-1.008)        0.347
  LP                         23 (12-45)              28 (15-54)            1.006 (0.997-1.016)        0.191
  CRP                        5.75 (4.9-7)            6.35 (4.82-8.57)      1.001 (0.99-1.013)         0.814
  LDL                        82 (59-105)             86 (68-114)           1.003 (0.997-1.009)        0.280
  HDL                        40.3 ± 8.5              42.8 ± 9.37           1.031 (1-1.062)            0.049
  No. of diseased vessel                                                                              0.473
  1                          19 (3.7)                2 (3.8)                                          
  2                          99 (19.4)               7 (13.2)              0.616 (0.127-2.976)        0.547
  3                          393 (76.9)              44 (83)               1.013 (0.245-4.191)        0.985
  No. of grafts              3.7 ± 0.94              3.9 ± 1.02            1.234 (0.922-1.650)        0.158
  Euro score                                                                                          0.017
  Low (0-2)                  301 (58.9)              20 (37.7)                                        
  Moderate (3-5)             171 (33.5)              25 (47.2)             2.089 (1.160-3.762)        0.014
  High (6-8)                 32 (6.3)                6 (11.3)              2.851 (1.143-7.110)        0.025
  Very high (≥ 9)            7 (1.4)                 2 (3.8)               4.479 (1.044-19.220)       0.044

Data are shown as mean ± SD, median (25^th^-75^th^ percentiles) or number (%). BMI: Body mass index; FC: Functional class; EF: Ejection fraction; FH: Family history; DM: Diabetes mellitus; HLP: Hyperlipidemia; HTN: Hypertension; CVA: Cerebrovascular accident; PVD: Peripheral vascular disease; MI: Myocardial infarction; Alb: Albumin; FBS: Fasting blood sugar; BUN: Blood urea nitrogen; Cr: Creatinine; Mg: Magnesium; HCT: Hematocrit; TG: Triglyceride; Chol: Cholestrol; LP: Lipoprotein; CRP: C-reactive protein; LDL: Low density lipoprotein; HDL: High density lipoprotein.

The frequency of moderate, high and very high risk EuroSCORE was significantly higher in non-survivors as compared to survivors. However, the number of diseased vessels and performed bypass grafts was similar between the both groups.

Table [2](#T2){ref-type="table"} shows patients' baseline demographic and clinical characteristics generally and based on opium consumption. Mean ± SD age of patients was 59.08 ± 8.9 years and 75.1% were men. History of opium consumption was present in 14.5%. Forty-one percent had diabetes mellitus and 3.9% had history of cerebrovascular accident. Body mass index and EF mean ± SD was 27.3 ± 4.08 kg/m^2^ and 48.5% ± 10.3%, respectively. Functional class III was documented in 14.7% of patients. Opium users were significantly more often men, younger, smoker and also alcohol consumer.

###### 

Baseline characteristics of patients base on opium consumption

                             **All patients (*n* = 566)**   **Opium + (*n* = 82)**   **Opium - (*n* = 484)**   ***P* value**
  -------------------------- ------------------------------ ------------------------ ------------------------- ---------------
  Age (yr)                   59.08 ± 8.9                    55.9 ± 8.3               59.6 ± 8.9                \< 0.001
  Gender (male)              425 (75.1)                     80 (97.6)                345 (71.3)                \< 0.001
  BMI (kg/m^2^)              27.3 ± 4.08                    25.7 ± 3.6               27.6 ± 4.08               \< 0.001
  Waist circumference (cm)   101.3 ± 11.3                   100.3 ± 9.3              101.5 ± 11.6              0.514
  FC                                                                                                           0.531
  I                          198 (35)                       33 (40.2)                165 (34.2)                
  II                         283 (50)                       39 (47.6)                244 (50.6)                
  III                        83 (14.7)                      10 (12.2)                73 (15.1)                 
  EF (%)                     48.5 ± 10.3                    44.9 ± 9.4               49.1 ± 10.3               0.001
  FH                         269 (47.5)                     44 (53.7)                225 (46.7)                0.242
  Smoking                    203 (35.9)                     67 (81.7)                136 (28.2)                \< 0.001
  Alcohol                    71 (12.5)                      29 (37.7)                42 (9.2)                  \< 0.001
  DM                         232 (41)                       26 (31.7)                206 (42.7)                0.061
  HLP                        398 (70.3)                     48 (58.5)                350 (72.6)                0.010
  HTN                        279 (49.3)                     30 (36.6)                249 (51.7)                0.012
  CVA                        22 (3.9)                       4 (4.9)                  18 (3.7)                  0.545
  PVD                        158 (27.9)                     21 (25.6)                137 (28.4)                0.600
  MI                         286 (50.5)                     58 (71.6)                228 (47.5)                \< 0.001
  Alb (g/dL)                 4.6 ± 0.3                      4.5 ± 0.3                4.6 ± 0.3                 0.200
  FBS                        96 (87-118)                    92 (81-106)              97 (88-119)               0.011
  BUN                        38 (31-46)                     35 (27-42)               39 (32-47)                0.004
  Cr                         1.2 ± 0.2                      1.3 ± 0.3                1.2 ± 0.2                 0.024
  Mg                         1.9 ± 0.3                      1.8 ± 0.3                1.9 ± 0.3                 0.314
  HCT                        42.3 ± 5.7                     42.2 ± 3.6               42.4 ± 6.04               0.848
  TG                         159 (113-205)                  150 (107-194)            162 (113-208)             0.353
  Chol                       157 (129-186)                  156 (124-177)            157 (129-188)             0.167
  LP                         23 (12-46)                     24 (9-44)                23 (13-47)                0.432
  CRP                        5.8 (4.9-7.2)                  5.8 (4.8-7.1)            5.8 (4.9-7.2)             0.617
  LDL                        83 (60-106)                    85 (60.7-100.5)          82.5 (60-110)             0.517
  HDL                        40.5 ± 8.6                     39.4 ± 8.5               40.7 ± 8.6                0.205
  No. of diseased vessel                                                                                       0.733
  1                          21 (307)                       2 (2.4)                  19 (3.9)                  
  2                          106 (18.7)                     17 (20.7)                89 (18.5)                 
  3                          437 (77.2)                     63 (76.8)                374 (77.6)                
  No. of grafts              4 (3-4)                        4 (3-5)                  4 (3-4)                   0.400
  Euro score                                                                                                   0.199
  Low (0-2)                  321 (56.7)                     45 (54.9)                276 (57.3)                
  Moderate (3-5)             196 (34.6)                     26 (31.7)                170 (35.5)                
  High (6-8)                 38 (6.7)                       10 (12.2)                28 (5.8)                  
  Very high (≥ 9)            9 (1.6)                        1 (1.2)                  8 (1.7)                   

Data are shown as mean ± SD, median (25^th^-75^th^ percentiles) or number (%). BMI: Body mass index; FC: Functional class; EF: Ejection fraction; FH: Family history; DM: Diabetes mellitus; HLP: Hyperlipidemia; HTN: Hypertension; CVA: Cerebrovascular accident; PVD: Peripheral vascular disease; MI: Myocardial infarction; Alb: Albumin; FBS: Fasting blood sugar; BUN: Blood urea nitrogen; Cr: Creatinine; Mg: Magnesium; HCT: Hematocrit; TG: Triglyceride; Chol: Cholesterol; LP: Lipoprotein; CRP: C-reactive protein; LDL: Low density lipoprotein; HDL: High density lipoprotein.

Patients with positive history of opium consumption also significantly tended to have lower EF (44.9 ± 9.4 *vs* 49.1 ± 10.3), higher Cr (1.3 ± 0.3 *vs* 1.2 ± 0.2) and higher prevalence of MI (71.6% *vs* 47.5%). On the other hand, the level of BMI and fasting blood sugar and prevalence of hyperlipidemia (HLP), hypertension were significantly lower in these patients.

Opium-stratified survival
-------------------------

Based on follow-up information, 6.5 years (78.7 mo) overall survival was 91.8% (95%CI: 89.5%-94.2%). When analyzed based on habitual history of opium consumption, 6.5-year (78.7 mo) overall survival was found to be 86.6% (95%CI: 79.1%-94.7%) in opium users and 92.7% (95%CI: 90.3%-95.1%) in non-opium users.

After adjustments for confounding variables such as age, BMI, EF, diabetes, alcohol, HLP, MI, Cr, BUN and EuroSCORE, we found an evidence of predicting mortality for opium with a borderline *P* value (HR = 2.16; 95%CI: 0.96-4.84; *P* = 0.06) (Figure [1](#F1){ref-type="fig"}). As appears from curves, opium users have a trend to worse long-term survival as compared to non-opium consumers.

![Adjusted survival curves based on opium consumption.](WJC-8-676-g001){#F1}

Multiple predictors of all-cause mortality
------------------------------------------

Multiple Cox regression for predictors of all-cause mortality is described in Table [3](#T3){ref-type="table"}. As demonstrated, age, BMI, EF, diabetes mellitus and cerebrovascular accident remained the significant independent predictors of all-cause mortality. We found a trend of increasing risk of all-cause mortality by increasing age and functional class. A converse trend for all-cause mortality was noted by increasing BMI and EF. As shown, cerebrovascular accident had the greatest HR for mortality (HR = 3.45; 95%CI: 1.3-9.1, *P* = 0.013).

###### 

Multivariable model for all-cause mortality using Cox regression

                             **Hazard ratio (95%CI)**   ***P* value**
  -------------------------- -------------------------- ---------------
  Age (per 10 yr increase)   2.46 (1.64-3.70)           \< 0.001
  Opium                      2.09 (0.99-4.39)           0.052
  BMI                        0.89 (0.82-0.96)           0.004
  FC                                                    0.653
  II *vs* I                  0.86 (0.44-1.66)           0.653
  III *vs* II                2.18 (0.97-4.88)           0.057
  EF (per 5% increase)       0.71 (0.62-0.81)           \< 0.001
  DM                         2.97 (1.59-5.54)           0.001
  CVA                        3.45 (1.30-9.16)           0.013

BMI: Body mass index; FC: Functional class; EF: Ejection fraction; DM: Diabetes mellitus; CVA: Cerebrovascular accident.

Smoking rate was not significantly different between survivors and non-survivors (Table [1](#T1){ref-type="table"}). However, due to high coincidence of smoking and opium addiction (Table [2](#T2){ref-type="table"}) we adjusted the results by adding the history of smoking to the list of predictors of long-term mortality which reduced the HR of opium for mortality from 2.09 to 1.20 (95%CI: 0.819-1.745, *P* = 0.355) (Table [3](#T3){ref-type="table"}).

DISCUSSION
==========

The current study represents the overall and opium-based stratified survival of patients undergoing CABG surgery who were followed-up for a median time of 78.7 mo. The prevalence of opium addiction was found to be 14.5% in our study. To our knowledge, studies are lacking to clarify the long-term effects of opium consumption on survival of patients undergoing CABG surgery. One of the notable points of our study was relatively long duration of follow-up.

Considering overall survival of patients undergoing CABG surgery, we found an overall survival of 91.8% in 6.5 years (78.7 mo). Five-year survival has been reported 72.1% in Yoo et al\[[@B21]\]'s study and Dunning et al\[[@B22]\] identified a ten-year survival of 66%. Meanwhile unadjusted 5 and 10-year survivals have been reported 83.8% and 65% in Filardo et al\[[@B1]\]'s research.

We identified that age, BMI, EF, diabetes mellitus and cerebrovascular accident could independently and significantly predict all-cause mortality of patients undergoing CABG surgery. Findings of Leavitt et al\[[@B5]\], Marcheix et al\[[@B23]\] and Barsness et al\[[@B24]\] support our results in terms of adverse effect of diabetes mellitus on long-term survival. Interestingly cerebrovascular accident had the greatest HR of 3.45 in predicting mortality by multiple Cox regression analysis suggesting that non-cardiac comorbidities may play an important role in patients' outcomes as well as unfavorable cardiac performance.

We found a significant HR of 0.89 for BMI in predicting overall mortality. Our results were in accordance with those reported in Gruberg et al\[[@B25]\]'s work. They found that overweight or obese patients under CABG have significantly better survival outcomes at 3-year follow-up than those with normal BMI. The phenomenon obesity-mortality paradox which is generally accepted in short term outcome studies is described by better outcome in patients with higher BMI compared to the others. However, there is no consensus in long term investigations as Del Prete et al\[[@B26]\] noted that long-term survival was not significantly different between obese and non-obese patients after making adjustment model (HR = 1.2, *P* = 0.2). This is partially explained by increasing rate of complications due to major cardiovascular risk factors and substantial re stenosis in grafted coronary arteries by time\[[@B27],[@B28]\]. Though we followed our patients for long period of time we found that BMI was still a predictor of mortality. Low mortality rate in our cohort compared to other studies with similar time intervals that reflect lower risks and complications in our patients could be an explanation. The other reason may be the finding of missed to follow up in a group of our patients which decreases the median time of overall follow-up.

Opium can potentially cause coronary atherosclerosis and increase cardiovascular mortality in different ways. Some metabolic changes by opium that could have deleterious effects on cardiovascular system include: Decreasing plasma testosterone and estrogen, and increasing plasma prolactin, increasing insulin resistance, increasing inflammation as well as oxidative stress, increasing fibrinogen and factor VII, and decreasing apolipoprotein A, increasing the release of nitric oxide and inhibiting production and release of hydrogen peroxide. Moreover, opium can decrease myocardial oxygenation from different ways that could extend infarct size and increase probability of death\[[@B29],[@B30]\].

The role of opium in CAD remains controversial. Masoomi et al\[[@B13]\] showed that opium was an independent risk factor of CAD in non-smoker patients. But findings of Sadeghian et al\[[@B14]\]'s research on 4398 isolated CABG patients and opium dependence rate of 15.6%, found no relationship between post CABG in hospital complications and opium addiction. But on the other hand, in a study conducted by Safaii et al\[[@B15]\] on 6-mo outcomes of CABG patients, opium usage leaded to more readmission following CABG operation.

We found a HR of 2.1 for mortality in opium consumers as compared to patients who did not use opium with a borderline *P* value of 0.06. Since the rate of smoking is higher among opium-consumers, when we further adjusted the results by smoking, we observed that the role of smoking would be more prominent in predicting mortality so that HR for opium decreased to 1.2. Though our findings are not in favor of any protective role for opium in smoker cardiac patients, there is still no evidence to consider opium as a risk marker for long term survival in this group too.

The main problem with clarifying pure effect of opium on long term outcome in cardiac patients is high co incidence of smoking and opium addiction (Table [2](#T2){ref-type="table"}). In deed there were only 15 patients who were opium users and non-smokers in our cohort. We need to perform further investigation to clarify pure effect of opium, because ignoring the adverse effects of opium and attributing any poor clinical outcomes to the smoking alone would be potentially associated with worse consequences.

There are other obstacles to detect the effects of opium on outcome in coronary patients that has been discussed elsewhere\[[@B30],[@B31]\]. Briefly there are variations in self-reported dosage, route of usage, and purity of consumed opium. The other important issue probably would be the reason for beginning opium consumption: recreational or for pain relief\[[@B29],[@B30]\].

In conclusion, in the present study, we found advanced age, low EF, DM and CVA as predictors for long term mortality. However, due to the simultaneous impact of smoking as a confounding variable neither the cardio protective role of opium in ischemic phase suggested in some studies nor its role as a predictor for long-term survival of CABG patients could be justified. Further large sample size studies are needed to clarify pure opium role and verify the aforementioned findings.
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